Join
Live feed
·
PRReleasevia Quantisnow
Alcon Inc. logo

Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease

ByQuantisnow·Wall Street's wire, on your screen.
ALC· Alcon Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALC (Alcon Inc.) and more on Quantisnow.